Stuart A Arbuckle Insider Trading $VRTX VERTEX PHARMACEUTICALS INC / MA

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Stuart A Arbuckle.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Stuart A Arbuckle. Stuart A Arbuckle is Director in IMMUNOGEN INC ($IMGN) and EVP, Chief Commercial Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP\Chief Commercial Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in Cerulean Pharma Inc. ($CERU) and Director in RHYTHM PHARMACEUTICALS, INC. ($RYTM).

Stuart A Arbuckle in VERTEX PHARMACEUTICALS INC / MA

Trading Symbol: VRTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stuart A Arbuckle: EVP, Chief Commercial Officer, EVP\Chief Commercial Officer
Holdings: 44,737 shares
Current Value: $3,884,961
Latest Transaction: Feb 26 2021
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Stuart A Arbuckle in VERTEX PHARMACEUTICALS INC / MA

Sentiment: All, DARE, IMGN, RYTM, VRTX

Page: < prev 1 2 3

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 05 2017	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	124.00	13,594	1,685,656	131,467	145.1 K to 131.5 K (-9.37 %)
Jun 05 2017	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	53.74	13,594	730,542	145,061	131.5 K to 145.1 K (+10.34 %)
May 02 2017	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	45.11	28,320	1,277,515	0
May 02 2017	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	119.50	28,320	3,384,240	131,247	159.6 K to 131.2 K (-17.75 %)
May 02 2017	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	45.11	28,320	1,277,515	159,567	131.2 K to 159.6 K (+21.58 %)
Feb 15 2017	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	88.39	3,792	335,175	127,455	131.2 K to 127.5 K (-2.89 %)
Feb 07 2017	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	A	86.52	24,852	2,150,195	24,852
Feb 07 2017	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Grant	A	0.00	12,136	0	131,247	119.1 K to 131.2 K (+10.19 %)
Feb 07 2017	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Grant	A	0.01	5,753	58	119,111	113.4 K to 119.1 K (+5.08 %)
Nov 14 2016	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	90.00	1,208	108,720	113,358	114.6 K to 113.4 K (-1.05 %)
Oct 05 2016	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	86.46	1,208	104,444	114,566	115.8 K to 114.6 K (-1.04 %)
May 27 2016	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Gift	G	0.00	150	0	115,774	115.9 K to 115.8 K (-0.13 %)
Feb 04 2016	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	A	91.05	34,482	3,139,586	34,482
Feb 04 2016	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	92.80	645	59,856	115,721	116.4 K to 115.7 K (-0.55 %)
Feb 04 2016	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	91.89	700	64,323	116,366	117.1 K to 116.4 K (-0.60 %)
Feb 04 2016	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	90.98	2,100	191,058	117,066	119.2 K to 117.1 K (-1.76 %)
Feb 04 2016	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	89.92	2,597	233,522	119,166	121.8 K to 119.2 K (-2.13 %)
Feb 04 2016	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Grant	A	0.01	17,299	173	121,763	104.5 K to 121.8 K (+16.56 %)
Dec 08 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	53.74	4,531	243,496	13,594
Dec 08 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	125.17	100	12,517	104,464	104.6 K to 104.5 K (-0.10 %)
Dec 08 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	124.36	2,252	280,059	104,564	106.8 K to 104.6 K (-2.11 %)
Dec 08 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	123.53	2,179	269,172	106,816	109 K to 106.8 K (-2.00 %)
Dec 08 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	53.74	4,531	243,496	108,995	104.5 K to 109 K (+4.34 %)
Nov 18 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	77.31	3,650	282,182	38,250
Nov 18 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	124.00	3,650	452,600	104,464	108.1 K to 104.5 K (-3.38 %)
Nov 18 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	123.00	100	12,300	108,114	108.2 K to 108.1 K (-0.09 %)
Nov 18 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	122.47	143	17,513	108,214	108.4 K to 108.2 K (-0.13 %)
Nov 18 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	121.95	184	22,439	108,357	108.5 K to 108.4 K (-0.17 %)
Nov 18 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	77.31	3,650	282,182	108,541	104.9 K to 108.5 K (+3.48 %)
Nov 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	77.31	600	46,386	41,900
Nov 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	45.11	5,664	255,503	28,320
Nov 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	125.17	200	25,034	104,748	104.9 K to 104.7 K (-0.19 %)
Nov 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	124.59	1,220	152,000	104,948	106.2 K to 104.9 K (-1.15 %)
Nov 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	123.04	2,400	295,296	106,168	108.6 K to 106.2 K (-2.21 %)
Nov 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	122.46	2,444	299,292	108,568	111 K to 108.6 K (-2.20 %)
Nov 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	77.31	600	46,386	111,012	110.4 K to 111 K (+0.54 %)
Nov 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	45.11	5,664	255,503	110,412	104.7 K to 110.4 K (+5.41 %)
Nov 03 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	126.31	4,500	568,395	104,748	109.2 K to 104.7 K (-4.12 %)
Nov 03 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	125.30	3,950	494,935	109,248	113.2 K to 109.2 K (-3.49 %)
Nov 03 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	124.44	1,000	124,440	113,198	114.2 K to 113.2 K (-0.88 %)
Nov 03 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	123.36	900	111,024	114,198	115.1 K to 114.2 K (-0.78 %)
Oct 05 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	106.07	600	63,642	115,098	115.7 K to 115.1 K (-0.52 %)
Oct 05 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	105.41	5,058	533,164	115,698	120.8 K to 115.7 K (-4.19 %)
Oct 05 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	104.45	5,159	538,858	120,756	125.9 K to 120.8 K (-4.10 %)
Oct 05 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	103.28	900	92,952	125,915	126.8 K to 125.9 K (-0.71 %)
Oct 05 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	102.30	700	71,610	126,815	127.5 K to 126.8 K (-0.55 %)
Sep 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	53.74	9,063	487,046	18,125
Sep 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	126.44	3,463	437,862	127,515	131 K to 127.5 K (-2.64 %)
Sep 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	125.42	5,200	652,184	130,978	136.2 K to 131 K (-3.82 %)
Sep 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	124.43	400	49,772	136,178	136.6 K to 136.2 K (-0.29 %)
Sep 09 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	53.74	9,063	487,046	136,578	127.5 K to 136.6 K (+7.11 %)
Aug 07 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	77.31	8,500	657,135	42,500
Aug 07 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	45.11	11,328	511,006	33,984
Aug 07 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	142.18	2,300	327,014	127,515	129.8 K to 127.5 K (-1.77 %)
Aug 07 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	141.36	13,328	1,884,046	129,815	143.1 K to 129.8 K (-9.31 %)
Aug 07 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	140.51	4,200	590,142	143,143	147.3 K to 143.1 K (-2.85 %)
Aug 07 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	77.31	8,500	657,135	147,343	138.8 K to 147.3 K (+6.12 %)
Aug 07 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	45.11	11,328	511,006	138,843	127.5 K to 138.8 K (+8.88 %)
Jul 23 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	A	131.89	34,000	4,484,260	34,000
May 18 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	123.85	148	18,330	127,515	127.7 K to 127.5 K (-0.12 %)
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	77.31	17,000	1,314,270	51,000
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	45.11	15,563	702,047	45,312
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	M	53.74	18,312	984,087	27,188
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	134.05	700	93,835	127,515	128.2 K to 127.5 K (-0.55 %)
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	133.34	3,400	453,356	128,215	131.6 K to 128.2 K (-2.58 %)
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	132.44	6,316	836,491	131,615	137.9 K to 131.6 K (-4.58 %)
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	131.27	4,230	555,272	137,931	142.2 K to 137.9 K (-2.98 %)
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	130.33	11,321	1,475,466	142,161	153.5 K to 142.2 K (-7.38 %)
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	129.30	1,100	142,230	153,482	154.6 K to 153.5 K (-0.71 %)
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	128.17	12,933	1,657,623	154,582	167.5 K to 154.6 K (-7.72 %)
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	127.49	21,480	2,738,485	167,515	189 K to 167.5 K (-11.37 %)
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	77.31	17,000	1,314,270	188,995	172 K to 189 K (+9.88 %)
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	45.11	15,563	702,047	171,995	156.4 K to 172 K (+9.95 %)
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Buy	M	53.74	18,312	984,087	156,432	138.1 K to 156.4 K (+13.26 %)
Apr 29 2015	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Gift	G	0.00	150	0	138,120	138.3 K to 138.1 K (-0.11 %)
Dec 12 2013	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	65.47	3,021	197,785	36,718	39.7 K to 36.7 K (-7.60 %)
Oct 03 2013	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	76.49	8,982	687,033	39,334	48.3 K to 39.3 K (-18.59 %)
Oct 03 2013	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	75.73	3,435	260,133	48,316	51.8 K to 48.3 K (-6.64 %)
Aug 01 2013	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	A	83.36	34,000	2,834,240	34,000
Jul 31 2013	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Sell	S	79.87	347	27,715	51,751	52.1 K to 51.8 K (-0.67 %)
Feb 07 2013	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	A	45.11	90,625	4,088,094	90,625
Feb 07 2013	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Grant	A	0.01	12,084	121	51,751	39.7 K to 51.8 K (+30.46 %)
Sep 06 2012	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Option Exercise	A	53.74	72,500	3,896,150	72,500
Sep 06 2012	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Grant	A	0.01	30,000	300	39,667	9.7 K to 39.7 K (+310.33 %)
Sep 06 2012	VRTX	VERTEX PHARMACEUTI ...	Arbuckle Stuart A	EVP\Chief Commercia ...	Grant	A	0.01	9,667	97	9,667	0 to 9.7 K

Page: < prev 1 2 3